JKJustin Kua

Justin Kua

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Justin Kua has a total of 101 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Peri‐operative glucagon‐like peptide‐1 receptor agonist use and outcomes: a national prospective multicentre cohort study

    by Thomas E. Potter, John N. Cronin, Justin Kua, Sophie Bloomfield, Mayur Murali, Frances Beatty, Andrew McKechnie, Danny J. N. Wong, Kariem El-Boghdadly, the GLIMPSE Resident Research Networks and Collaborators

    Summary: Introduction: Peri‐operative glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) use is associated with delayed gastric emptying. It is unclear what proportion of patients having anaesthetic care are receiving GLP‐1 RAs; what strategies are used in their peri‐operative management; and whether the incidence of pulmonary aspiration and/or regurgitation is greater in this population. Methods: We performed a national prospective multicentre cohort study of adults undergoing elective or emergency procedures under the care of an anaesthetist. Patients were screened for GLP‐1 RA use in the 3 months before the index procedure. Data were collected on patient, procedure, anaesthesia and outcomes, including pulmonary aspiration and regurgitation. The primary outcome was the proportion of patients receiving GLP‐1 RAs. Secondary outcomes described the pre‐operative management of GLP‐1 RAs; anaesthesia and airway management in patients receiving GLP‐1 RAs; and the incidence of pulmonary aspiration and/or regurgitation. Results: Of 47,039 patients from 119 sites across the UK, 1348 (2.9%) reported receiving GLP‐1 RAs. Peri‐operative management was variable regarding drug cessation, anaesthesia and airway management. The incidence (95%CI) of pulmonary aspiration and/or regurgitation in the non‐GLP‐1 RA cohort was 57/45,691 (0.12% (0.09–0.16%)) and in the GLP‐1 RA cohort was 19/1348 (1.41% (0.85–2.19%)); odds ratio (95%CI) 11.39 (6.47–20.05), p < 0.001. In patients receiving GLP‐1 RAs, pulmonary aspiration and/or regurgitation occurred most frequently during emergence from anaesthesia. Discussion: In this national study, 1 in 36 patients undergoing anaesthesia care received GLP‐1 RAs, and their peri‐operative management was variable. A range of airway management techniques aiming to reduce pulmonary aspiration risk were observed but, despite this, the incidence of pulmonary aspiration and/or regurgitation was 1 in 71 in people receiving GLP‐1 RAs.


  • Top Cited Papers
    Open Access

    The Postponement and Cancellations in Elective Care study: a national evaluation of case postponements and cancellations in elective surgical pathways

    by James Bedford, Emma McCone, Adam Hunt, Eleanor Warwick, Iain Moppett, Martha Belete, Laura Cortes, Sarah Hayden, Andrew Kane, Justin Kua, et al.


  • Open Access

    Snapshot of Obstetric National Audit and Research Project (SONAR1): aprotocol for an international observational cohort study

    by Reshma Patel, James O’cArroll, Justin Kua, Pervez Sultan, Brendan Carvalho, Nadir El Sharawi, Victoria Eley, Pat O’bRien, Susanna Stanford, Samantha Hill, et al.

    Introduction Caesarean birth (CB) under neuraxial anaesthesia (NA) is the most performed inpatient operation in the UK. The incidence of intraoperative pain during caesarean delivery performed under neuraxial anaesthesia is unclear, with limited data that used patient-reported measures to investigate intraoperative pain. The short- and medium-term impacts on patients of this adverse event are unknown. Methods and analysis We will undertake a multicentre, prospective observational cohort study to evaluate the incidence and impact of pain experienced by patients during CB performed under neuraxial anaesthesia. Routine audit data will be collected for all patients undergoing caesarean delivery for any indication during a 1 week window at participating hospitals within the UK and Queensland, Australia. The dataset will include patient, anaesthetic, obstetric and neonatal risk factors for intraoperative pain. Local investigators will then seek informed consent from patients either before or within 24 hours of delivery to record patient experience and patient-reported outcomes at 24 hours and 6 weeks postdelivery. Local investigators at participating hospitals will also complete a survey evaluating compliance with evidence-based structural standards at their sites. The patient characteristics, structures, processes and outcomes will be described. Inferential techniques will be used to evaluate the relationship between risk factors and postoperative outcomes. Ethics and dissemination This study received ethical approval from the Leicester Health Research Authority and Care Research Wales, REC reference 24/EM/0084) on 24 May 24. The study received ethical approval from the Human Research Ethics Committee of Metro North Health in Australia on 25 March 2024 (REC Ref HREC/2024/MNHA/103767). The results of the study will be reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology statement. The results will be disseminated via conference presentations, peer-reviewed academic journals and reports prepared for patients, the public and policy makers. Trial registration number ISRCTN15269213.


  • Racial and ethnic disparity in obstetric anaesthesia: a systematic review and meta‐analysis

    by Robert Craig, Shaima El Nour, Lauren Borg Xuereb, Alexander Gibbs, Sureka Suriyakumar, Lindsay Blake, Anna L. David, Allison Lee, Diane Nzelu, S. Ramani Moonesinghe, et al.

    Summary: Introduction: Racial and ethnic disparities in obstetrics persist globally despite improvements in maternal mortality rates and are related to access, experience and outcomes. We aimed to elucidate the racial and ethnic disparity in obstetric analgesia and anaesthesia. Methods: Databases were searched and we included studies published in the English language conducted in all countries. Search terms included terminology concerning obstetric anaesthesia related to race or ethnicity. Included papers were assessed for risk of bias. Studies were included for detailed review if they described disparities relating to obstetric anaesthesia between two or more racial or ethnic groups. Results: In total, 1806 abstracts were screened of which 25 articles were included and data from 19 could be pooled for meta‐analysis using a random effects model. Outcome measures included disparities in labour neuraxial analgesia utilisation and general anaesthesia use for caesarean delivery. Sixteen observational studies examined labour neuraxial analgesia, representing data from 13,398,421 patients in the USA and UK. Patients categorised as Asian or Black had lower odds of receiving neuraxial analgesia when compared with those from White backgrounds (odds ratios (95%CI) 0.80 (0.65–0.99) and 0.72 (0.61–0.85), respectively). Six studies examined the use of general anaesthesia for caesarean delivery in 2,139,763 patients. Black patients were more likely to receive general anaesthesia compared with White patients (odds ratio (95%CI) 1.60 (1.15–2.22)). Risk of bias assessments showed high or very high risk of bias in 13 of the 25 included studies. Discussion: Racial and ethnic disparities exist in obstetric anaesthesia. Further research to elucidate causes and ongoing action to minimise them are crucial.


  • Open Access

    UK ‐wide rates of videolaryngoscopy use and barriers to universal uptake: a retrospective analysis of a multicentre observational study

    by J. Kua, T. Potter, D. J. N. Wong, E. Nurmi, K. El‐Boghdadly, J. N. Cronin


  • Open Access

    Postoperative mortality and complications in patients with and without pre‐operative SARS‐CoV‐2 infection: a service evaluation of 24 million linked records using OpenSAFELY

    by C. D. McInerney, A. Kotzé, S. Bacon, J. E. Cutting, L. Fisher, B. Goldacre, O. A. Johnson, J. Kua, D. McGuckin, A. Mehrkar, et al.

    Summary: Surgical decision‐making after SARS‐CoV‐2 infection is influenced by the presence of comorbidity, infection severity and whether the surgical problem is time‐sensitive. Contemporary surgical policy to delay surgery is informed by highly heterogeneous country‐specific guidance. We evaluated surgical provision in England during the COVID‐19 pandemic to assess real‐world practice and whether deferral remains necessary. Using the OpenSAFELY platform, we adapted the COVIDSurg protocol for a service evaluation of surgical procedures that took place within the English NHS from 17 March 2018 to 17 March 2022. We assessed whether hospitals adhered to guidance not to operate on patients within 7 weeks of an indication of SARS‐CoV‐2 infection. Additional outcomes were postoperative all‐cause mortality (30 days, 6 months) and complications (pulmonary, cardiac, cerebrovascular). The exposure was the interval between the most recent indication of SARS‐CoV‐2 infection and subsequent surgery. In any 6‐month window, < 3% of surgical procedures were conducted within 7 weeks of an indication of SARS‐CoV‐2 infection. Mortality for surgery conducted within 2 weeks of a positive test in the era since widespread SARS‐CoV‐2 vaccine availability was 1.1%, declining to 0.3% by 4 weeks. Compared with the COVIDSurg study cohort, outcomes for patients in the English NHS cohort were better during the COVIDSurg data collection period and the pandemic era before vaccines became available. Clinicians within the English NHS followed national guidance by operating on very few patients within 7 weeks of a positive indication of SARS‐CoV‐2 infection. In England, surgical patients' overall risk following an indication of SARS‐CoV‐2 infection is lower than previously thought.


  • Clinical evidence needed for risks of PPE

    by J. Kua, E. Nurmi, D. J. N. Wong, T. Potter, J. N. Cronin, K. El‐Boghdadly

  • Open Access

    Aerosol precautions and airway complications: a national prospective multicentre cohort study

    by T. Potter, J. N. Cronin, J. Kua, E. Nurmi, D. J. N. Wong, I. Ahmad, T. M. Cook, K. El‐Boghdadly, the AeroComp Trainee Research Networks, Collaborators

    Summary: The perceived risk of transmission of aerosolised viral particles from patients to airway practitioners during the COVID‐19 pandemic led to the widespread use of aerosol precautions, including personal protective equipment and modifications to anaesthetic technique. The risk of these aerosol precautions on peri‐operative airway complications has not been assessed outside of simulation studies. This prospective, national, multicentre cohort study aimed to quantify this risk. Adult patients undergoing general anaesthesia for elective or emergency procedures over a 96‐hour period were included. Data collected included use of aerosol precautions by the airway practitioner, airway complications and potential confounding variables. Mixed‐effects logistic regression was used to assess the risk of individual aerosol precautions on overall and specific airway complications. Data from 5905 patients from 70 hospital sites were included. The rate of airway complications was 10.0% (95%CI 9.2–10.8%). Use of filtering facepiece class 2 or class 3 respirators was associated with an increased risk of airway complications (odds ratio 1.38, 95%CI 1.04–1.83), predominantly due to an association with difficult facemask ventilation (odds ratio 1.68, 95%CI 1.09–2.61) and desaturation on pulse oximetry (odds ratio 2.39, 95%CI 1.26–4.54). Use of goggles, powered air‐purifying respirators, long‐sleeved gowns, double gloves and videolaryngoscopy were not associated with any alteration in the risk of airway complications. Overall, the use of filtering facepiece class 2 or class 3 respirators was associated with an increased risk of airway complications, but most aerosol precautions used during the COVID‐19 pandemic were not.


  • Top Cited Papers
    Open Access

    Timing of elective surgery and risk assessment after SARS‐CoV ‐2 infection: an update

    by K. El‐Boghdadly, T. M. Cook, T. Goodacre, J. Kua, S. Denmark, S. McNally, N. Mercer, S. R. Moonesinghe, D. J. Summerton

    Summary: The impact of vaccination and new SARS‐CoV‐2 variants on peri‐operative outcomes is unclear. We aimed to update previously published consensus recommendations on timing of elective surgery after SARS‐CoV‐2 infection to assist policymakers, administrative staff, clinicians and patients. The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting. We recommend individualised multidisciplinary risk assessment for patients requiring elective surgery within 7 weeks of SARS‐CoV‐2 infection. This should include baseline mortality risk calculation and assessment of risk modifiers (patient factors; SARS‐CoV‐2 infection; surgical factors). Asymptomatic SARS‐CoV‐2 infection with previous variants increased peri‐operative mortality risk three‐fold throughout the 6 weeks after infection, and assumptions that asymptomatic or mildly symptomatic omicron SARS‐CoV‐2 infection does not add risk are currently unfounded. Patients with persistent symptoms and those with moderate‐to‐severe COVID‐19 may require a longer delay than 7 weeks. Elective surgery should not take place within 10 days of diagnosis of SARS‐CoV‐2 infection, predominantly because the patient may be infectious, which is a risk to surgical pathways, staff and other patients. We now emphasise that timing of surgery should include the assessment of baseline and increased risk, optimising vaccination and functional status, and shared decision‐making. While these recommendations focus on the omicron variant and current evidence, the principles may also be of relevance to future variants. As further data emerge, these recommendations may be revised.


  • Top Cited Papers

    Inadequate neuraxial anaesthesia in patients undergoing elective caesarean section: a systematic review

    by R. Patel, J. Kua, N. Sharawi, M.E. Bauer, L. Blake, S. R. Moonesinghe, P. Sultan

    Summary: Neuraxial anaesthesia is widely utilised for elective caesarean section, but the prevalence of inadequate intra‐operative anaesthesia is unclear. We aimed to determine the prevalence of inadequate neuraxial anaesthesia for elective caesarean section; prevalence of conversion from neuraxial anaesthesia to general anaesthesia following inadequate neuraxial anaesthesia; and the effect of mode of anaesthesia. We searched studies reporting inadequate neuraxial anaesthesia that used ≥ ED95 doses (effective dose in 95% of the population) of neuraxial local anaesthetic agents. Our primary outcome was the prevalence of inadequate neuraxial anaesthesia, defined as the need to convert to general anaesthesia; the need to repeat or abandon a planned primary neuraxial technique following incision; unplanned administration of intra‐operative analgesia (excluding sedatives); or unplanned epidural drug supplementation. Fifty‐four randomised controlled trials were included (3497 patients). The overall prevalence of requirement for supplemental analgesia or anaesthesia was 14.6% (95%CI 13.3–15.9%); 510 out of 3497 patients. The prevalence of general anaesthesia conversion was 2 out of 3497 patients (0.06% (95%CI 0.0–0.2%)). Spinal/combined spinal–epidural anaesthesia was associated with a lower overall prevalence of inadequate neuraxial anaesthesia than epidural anaesthesia (10.2% (95%CI 9.0–11.4%), 278 out of 2732 patients vs. 30.3% (95%CI 26.5–34.5%), 232 out of 765 patients). Further studies are needed to identify risk factors, optimise detection and management strategies and to determine long‐term effects of inadequate neuraxial anaesthesia.